Ohio launches a new fintech accelorator and we are helping

For the past 18 months, we’ve been assisting TeamNEO and JobsOH in the exploration and ultimate creation of a fintech accelerator (Fintech71). We will continue assisting Fintech71 as mentors to the accelerators selected companies.

For more information on Fintech71 please see http://www.marketwired.com/press-release/a-new-fintech-accelerator-emerges-backed-by-ohio-industry-giants-2211828.htm.

MCPF III is up and running!

Thank you to our existing and new investors for continuing to support Mutual Capital Partners. Our goal was to raise $40 million for fund three and we have closed on $43 million. Over the next 4-5 years, we will invest in 10 or so companies in the business to business software and medical device sectors.  Please contact us with any questions and we appreciate all investment opportunity introductions.

7signal Receives 2017 Cleveland Technology Award

The Cleveland Technology Awards Luncheon presented by Smart Business Magazine recognizes companies in Northeast Ohio that demonstrate innovative business practices to remain on the cutting edge of technology. Last week 7signal CEO Tom Barrett accepted the award at an awards luncheon in downtown Cleveland.

“I’m proud and honored to accept this award on behalf of 7signal,” stated Barrett.  “Receiving this is a reflection on the hard work our entire team has put into delivering great products that help companies manage their Wi-Fi networks everywhere.”

For more information on the awards, please visit http://www.sbnonline.com/article/cleveland-technology-awards-2017/

Cleveland HeartLab Adds Another Patent!

Cleveland HeartLab (CHL), the premier cardiovascular disease (CVD) management company, recently announced that a new patent for Myeloperoxidase (MPO) testing has been issued. CHL is the exclusive license holder for MPO testing, which is covered by a number of patents including this newly issued patent. Originally discovered and developed at the Cleveland Clinic, MPO testing has been recognized in over 100 peer-reviewed publications as a key measure of vascular inflammation. This new patent will add to the company’s already existing portfolio of intellectual property rights, which include 24 issued patents and an additional 17 pending patent applications. “This latest patent increases our intellectual property portfolio and further demonstrates CHL’s leadership in bringing valuable and innovative tests to market,” said Jake Orville, President and CEO.

According to the U.S. Department of Health and Human Services, Americans suffer 1.5 million heart attacks and strokes each year. CVD—including heart disease and stroke—is the leading cause of death in the U.S. Every day, 2,200 people die from CVD—that’s nearly 800,000 Americans each year, or 1 in every 3 deaths. According to the American Heart Association, half of those who suffer heart attacks and strokes have “normal” cholesterol levels, so tools such as MPO testing are desperately needed to improve our ability to assess CVD risk in patients whose risk is not revealed by cholesterol testing alone. The U.S. spends approximately $4 trillion on healthcare annually, one-sixth of which is spent treating CVD, according to the Centers for Disease Control and Prevention.  A recent publication in the Journal of Medical Economics demonstrated the use of MPO testing in combination with standard lipid testing could reduce heart attacks and strokes by approximately 10% compared to traditional cholesterol testing alone, not only saving lives but also hundreds of millions of healthcare dollars.

RevLocal Keeps on Winning!

RevLocal earned the number one spot on FranchiseRankings.com’s top 10 Best Franchise Web Marketing Suppliers list. FranchiseRankings.com is an independent guide that ranks franchises as well as businesses that provide franchise marketing services. To earn this ranking, businesses were evaluated on balance of strategy and methodology as well as criteria such as needs analysis, reporting methods, on-page optimization and more.

According to Jeev Trika, representative of FranchiseRankings.com, “RevLocal runs a very strong franchise focused optimization department. We have evaluated more than 50 companies, and RevLocal’s services are highly customized to franchises that want to surpass the competition,” Trika said.

RevLocal President Aaron Boggs said that RevLocal earned the top ranking on this list because of its brand-compliant franchise marketing practices. “It’s exciting to help accelerate franchise brands with an online marketing solution that works. We are helping solve a problem that faces a majority of the ‘zors and ‘zees we talk to. What RevLocal does is grow the Franchise brand, implement the marketing strategy and ensure brand compliance at the local level. Our customers love us because we actually provide a real relationship with every local ‘zee individually,” Boggs said.

He joined the board in 2016 and now has taken over as CEO in 2017!

We are pleased that Eric Timko has joined OrthAlign as CEO. Through our good friend Craig Markovitz in Pittsburgh, we were able to meet Eric last year and recruited him to the OrthAlign board. Eric and Craig were together at Blue Belt Technologies as the CEO and Co-Founder, respectively. Blue Belt Technologies was acquired by Smith & Nephew in 2015 for $275M on a $19M historical revenue base. Let’s hope that Eric can continue the orthopedic alignment magic at OrthAlign. For more information please visit http://www.orthalign.com/orthalign-inc-appoints-eric-b-timko-as-new-chief-executive-officer-and-chairman-of-the-board/.

56,000th Joint Arthroplasty Case Achieved!

OrthAlign continues a torrid pace of worldwide growth and has now been used in over 56,000 cases. Great technology assisting surgeons to provide better patient outcomes is at the core of the company’s mission and why we are so excited to be a part of the OrthAlign team. For more information, please visit http://www.orthalign.com/orthalign-inc-continues-impressive-worldwide-growth-in-2016-including-milestone-achievement-56000th-joint-arthroplasty-case/

RevLocal Remains the Leader in Local Search

Last week, RevLocal became the first ever recipient of the LSA Digital Marketer Certification, a recognition awarded by Local Search Association (LSA), a not-for-profit association specializing in local marketing. The program was launched today, and RevLocal was the first of only three companies to be awarded the certification.
To receive this certification, businesses must pass LSA’s stringent review process, which includes a review of business practices and employee training. LSA evaluates sales practices, service standards and employee training as well as client security and privacy before awarding the certification.
The certification is designed to help businesses find and compare trusted digital marketing providers. It will also teach businesses what to expect from their digital marketing efforts.
According to LSA, “Small businesses are finding it increasingly difficult to identify quality and reliable digital marketing partners to help promote their products and services. Forty-four percent of small business owners say they are challenged to find partners who deliver a return on investment, while 38 percent say they face hurdles selecting partners they can trust.”
LSA must find that businesses are committed to honesty, transparency and providing value to clients in order to award this certification.
RevLocal Company President, Aaron Boggs, says that RevLocal received this certification because of the company’s relationship-based approach to marketing.
“LSA has recognized that businesses are tired of being taken advantage of, and there has never been a greater need for a trusted digital marketing partner. The effort RevLocal puts into educating our consultants, who live in the communities they serve, is one of the things that sets us apart,” Boggs said.  “We are part of an industry that fails serve the customer or provide a relationship, but RevLocal is on a mission to fix this problem. We provide our clients with a team of experts who are with them every step of the way.”
For more information about RevLocal, please visit RevLocal.

OrthAlign Received FDA Clearance for Direct Anterior Approach HipAlign®

OrthAlign has the world’s first and only handheld alignment technology providing cup placement, leg length, and offset accuracy data for Direct Anterior Approach (DAA) in Total Hip Arthroplasty (THA) surgeries. Great work team and continued success in 2017!

For the full press release, please visit http://www.orthalign.com/orthalign-inc-announces-fda-clearance-for-direct-anterior-approach-hipalign/.